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Tonsillar cytokine expression 
between patients with tonsillar hypertrophy 
and recurrent tonsillitis
Emilia Mikola1, Varpu Elenius2†, Maria Saarinen2†, Oscar Palomares3,4,5, Matti Waris6,7, Riitta Turunen2, 
Tuomo Puhakka1,8, Lotta Ivaska1, Beate Rückert3,4, Alar Aab3,4, Tero Vahlberg9, Tytti Vuorinen6,7, 
Tobias Allander10, Carlos A. Camargo Jr11,12, Mübeccel Akdis3,4, Cezmi A. Akdis3,4 and Tuomas Jartti2* 
Abstract 
Background: Tonsils provide an innovative in vivo model for investigating immune response to infections and aller-
gens. However, data are scarce on the differences in tonsillar virus infections and immune responses between patients 
with tonsillar hypertrophy or recurrent tonsillitis. We investigated the differences in virus detection and T cell and 
interferon gene expression in patients undergoing tonsillectomy due to tonsillar hypertrophy or recurrent tonsillitis.
Methods: Tonsils of 89 surgical patients with tonsillar hypertrophy (n = 47) or recurrent tonsillitis (n = 42) were ana-
lysed. Patients were carefully characterized clinically. Standard questionnaire was used to asses preceding and allergy 
symptoms. Respiratory viruses were analysed in tonsils and nasopharynx by PCR. Quantitative real-time PCR was 
used to analyse intratonsillar gene expressions of IFN-α, IFN-β, IFN-γ, IL-10, IL-13, IL-17, IL-28, IL-29, IL-37, TGF-β, FOXP3, 
GATA3, RORC2 and Tbet.
Results: Median age of the subjects was 15 years (range 2–60). Patients with tonsillar hypertrophy were younger, 
smoked less often, had less pollen allergy and had more adenovirus, bocavirus-1, coronavirus and rhinovirus in 
nasopharynx (all P < 0.05). Only bocavirus-1 was more often detected in hypertrophic tonsils (P < 0.05). In age-adjusted 
analysis, tonsillar hypertrophy was associated with higher mRNA expressions of IL-37 (P < 0.05).
Conclusions: Intratonsillar T cell and interferon gene expressions appeared to be relatively stable for both tonsil-
lar hypertrophy and recurrent tonsillitis. Of the studied cytokines, only newly discovered anti-inflammatory cytokine 
IL-37, was independently associated with tonsillar hypertrophy showing slightly stronger anti-inflammatory response 
in these patients.
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Background
Tonsillar disease is one of the most common disorders in 
the field of otorhinolaryngology. Different types of ton-
sillar disease include recurrent tonsillitis and tonsillar 
hypertrophy, with both leading to symptoms of mouth 
breathing, snoring, dyspnea, apnea or dysphagia. Treat-
ment is usually antibiotics or tonsillectomy.
Tonsils are secondary lymphoid organs, which are 
centrally located at the beginning of the respiratory and 
gastrointestinal tracts where the immune system first 
comes into contact with infections agents and aller-
gens [1]. Surgically removed palatine tonsils provide 
a conventional accessible source to study the inter-
play between foreign pathogens, allergens and the host 
immune system. Our previous studies demonstrated 
that tonsils are organs where immune regulation takes 
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place in which allergen-specific regulatory T cells can 
be generated by mechanisms depending on plasmacy-
toid dendritic cells [2, 3]. The expression of T cell- and 
interferon specific genes in tonsils has been shown to 
be closely related to existing viral infections, age, and 
allergic illnesses [4, 5]. However, data are scarce on the 
differences in tonsillar virus infections and immune 
responses between patients with tonsillar hypertrophy 
or recurrent tonsillitis [6–8].
Tonsils appear to provide a good in  vivo model for 
investigating the mechanisms of inflammatory processes 
and infections in lymphoid organs [2–5]. Therefore, we 
studied whether virus detection and T cell and inter-
feron gene expressions differed between the two main 
indications of surgery, tonsillar hypertrophy or recurrent 
tonsillitis.
Methods
Patients
Human tonsil samples used in this study were acquired 
from 200 consecutive tonsillectomy patients who under-
went tonsillectomy in Satakunta Central Hospital, Pori, 
Finland between April 2008 and March 2009. The inclu-
sion criteria were elective tonsillectomy according to 
clinical indication and written informed consent from 
the study patient and/or his/her guardian. The study pro-
tocol was approved by the ethics committee of Satakunta 
Central Hospital, Pori, Finland. Study was initiated only 
after obtaining written consent from the participant or 
his/her guardian.
Study protocol and sample collection
A standard questionnaire was used to obtain informa-
tion on allergic diseases and respiratory symptoms within 
30 days before the operation (Additional file 1: Table 1). 
Tonsillectomy was performed according to routine clini-
cal procedure. Internal tonsillar tissue was immediately 
cut in 3–4  mm cubes, stored in RNAlater RNA stabili-
zation reagent (Qiagen, Hilden, Germany), incubated 
at +  4  °C until next working day and finally stored at 
− 80  °C after removal of the non-absorbed reagent. For 
viral analyses, a part of the tonsils and a nasopharyngeal 
aspirate were stored in dry tubes at −  80  °C [4]. Naso-
pharyngeal aspirate samples were obtained during anaes-
thesia using a standardized procedure [4]. Serum total 
25(OH)D measurement was done using an immunoassay 
(Abbott Architect, Chicago, USA) and bioavailable lev-
els of 25(OH)D were estimated using additional serum 
measurements (D-binding protein and albumin) and 
published formulae.
Definitions
Tonsillar hypertrophy group was defined as patients who 
underwent tonsillectomy because of obstructive symp-
toms such as snoring, breathing difficulties or swallow-
ing problems. There were no tonsillar infection problems 
in this group. Recurrent tonsillitis group was defined as 
patients who underwent tonsillectomy because of recur-
rently infected tonsils (viral or bacterial) during the past 
6–12 months. Those operated because of acute infection 
or peritonsillar abscess were excluded.
Analysis of viruses and cytokines
In-house real-time PCR assays were used to detect 
human bocavirus-1, rhinovirus, enterovirus, and respira-
tory syncytial virus as described previously [4]. Seeplex 
RV12 ACE Detection (Seegene, Seoul, Korea) multiplex 
PCR assay was used for detection of adenovirus, corona-
viruses (229E/NL63 and OC43/HKU1), influenza A and 
B viruses, metapneumovirus, parainfluenza virus types 
1-3, respiratory syncytial virus group A and B, and rhi-
novirus [4, 5]. Virus diagnostics were carried out in the 
Department of Virology, University of Turku, Turku, Fin-
land, and in the Department of Clinical Microbiology, 
Karolinska University Hospital, Stockholm, Sweden.
To isolate total RNA from palatine tonsils, tissues (pre-
viously stabilized in RNAlater) were homogenized in 
grinding tubes containing CK28 ceramic beads by using 
a Precellys 24 homogenizer (Bertin Technologies, Mon-
tigny le Bretonneux, France) two times at 6000  rpm 
for 50  s [4]. Total RNA from cell samples was isolated 
using the RNeasy mini kit (Qiagen, Hilden, Germany). 
Reverse transcription was performed with the Revert Aid 
M-MuLV Reverse Transcriptase (Fermentas, St. Leon-
Rot, Germany) using random hexamer primers according 
to the manufacturers protocol. Gene expressions of IFN-
α, IFN-β, IFN-γ, IL-10, IL-13, IL-17, IL-28, IL-29, IL-37, 
TGF-β, FOXP3, GATA3, RORC2 and Tbet were analysed 
by quantitative real-time PCR using iTaq SYBR Green 
Supermix with ROX (Bio-Rad, Hercules, CA, USA) on a 
7900HT Fast Real-Time PCR instrument (Applied Bio-
systems, Foster City, CA, USA). Housekeeping gene elon-
gation factor 1α (EF1α) was used for normalization. Data 
are shown as relative expressions, which show  2−(ΔCT) 
values multiplied by  104, where ΔCT corresponds to the 
difference between the CT value for the gene of interest 
and EF1α.
Statistical analysis
Continuous variables are described as medians and inter-
quartile ranges, and were analysed using Mann–Whitney 
U test due to skewed distribution. Categorical variables 
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are expressed as frequencies and percentages, and were 
analysed using Chi square test or Fisher exact test. Clini-
cal, viral and immunological differences between study 
groups were analysed using unadjusted and multivariable 
linear regression analysis. The adjustments for immu-
nologic analyses were chosen using backward stepwise 
multivariable models that initially included clinical fac-
tors and virus infections which significantly differed 
between the groups (age, self-reported pollen allergy, 
self-smoking, both adenotomy and tonsillectomy per-
formed, respiratory symptoms one month prior to the 
operation and bioavailable 25(OH)D level). The final 
model was adjusted only for age. Before regression anal-
yses, cytokine and transcription factor values were log-
transformed because of positively skewed distributions. 
The mean difference was computed for log-transformed 
values: a recurrently infected group minus hypertrophic 
group. Statistical analysis was completed using JMP 
version 12.0.1 software (SAS Institute Inc. Cary, NC, 
USA). A two-sided P < 0.05 was considered statistically 
significant.
Results
Study population
Originally, 200 patients participated in the study. Of 
them, 46 subjects did not have remaining tonsil and/
or nasopharyngeal samples for the current analysis, and 
11 had no intratonsillar virology done in their samples. 
Another 54 subjects were excluded for having mixed 
indications of operation other than hypertrophy or ton-
sillitis (Fig.  1). Thus, 89 patients comprised the analytic 
cohort. Forty-seven (53%) of them had tonsillar hypertro-
phy and 42 (47%) had recurrent tonsillitis.
Patient characteristics
All operations were performed during afebrile period 
of chronic tonsil condition. Respiratory symptoms on 
the operation day were present equally in the hyper-
trophy group and the recurrent tonsillitis group (15 
vs. 18%, respectively; P = 0.72). The median age of the 
patients was 8  years (range 2–46) and 20  years (range 
7–60), respectively (P < 0.001) (Table  1). In addition to 
being younger, patients in the hypertrophy group had 
more often adenotomy and tonsillectomy done, had 
Fig. 1 Study flow chart. 18 had hypertrophy and another indication (recurrent otitis media n = 4; recurrent otitis media and fever n = 3; recurrent 
fever n = 1). 29 had recurrent tonsillitis and another indication (recurrent fever n = 8; recurrent otitis media n = 1). 321 had hypertrophy and tonsillitis; 
8 had hypertrophy, tonsillitis, and another indication (recurrent fever, n = 5; recurrent otitis media, recurrent fever n = 1; recurrent otitis media n = 2). 
48 had other indication of operation than hypertrophy or tonsillitis (chronic white patches in tonsils n = 2; accumulation of food remnants, bad 
smelling breath, and feeling of beat in throat n = 1; recurrent fever n = 1; teeth braces n = 2; throat abscess n = 1; no clear cause n = 1)
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less self-reported pollen allergy, smoked less, and had 
less throat pain, but had more often rhinitis and cough 
1  month prior the operation and higher bioavailable 
25(OH)D level than patients in the recurrent tonsillitis 
group (all P < 0.01) (Table  1). Otherwise no significant 
differences were found between the two groups.
Viruses detected in nasopharyngeal aspirates and tonsils
Significantly more patients in the hypertrophy group, 
compared to the recurrent tonsillitis group, had a virus 
in their nasopharyngeal aspirates (79 vs. 38%, respec-
tively; P <0.001). In addition, patients in the hypertro-
phy group had more often adenovirus, bocavirus-1, 
coronavirus or rhinovirus in nasopharyngeal aspirate (all 
P < 0.05) (Table  2). However, intratonsillar virus detec-
tion didn’t show statistically significant differences, 
except for bocavirus-1 which was detected in tonsils in 
15% of patients with hypertrophy and only 2% of patients 
in recurrent tonsillitis group (Table  2). Patients in the 
hypertrophy group were more often positive for one 
Table 1 Patient characteristics
Values are shown as median (interquartile range, except age) or number of subjects (%). Data were analysed by Mann–Whitney U test, Chi square test, or Fisher’s Exact 
test
Significant values are shown in italic
Characteristics Tonsillar hypertrophy
n = 47
Recurrent tonsillitis
n = 42
P value
Age, years (range) 8 (2, 46) 20 (7, 60) < 0.0001
Male 27 (57%) 23 (55%) 0.80
Tonsillectomy and adenotomy 28 (60%) 5 (12%) < 0.0001
Self-reported allergy 20/43 (47%) 23/40 (58%) 0.32
 Food 6/43 (14%) 3/39 (8%) 0.38
 Drug 4/43 (9%) 4/39 (10%) 0.87
 Seasonal, i.e. pollen 0/43 (0%) 7/39 (18%) 0.004
 Perennial, i.e. animal or house dust mite 3/43 (7%) 2/39 (5%) 0.74
 Other 2/43 (5%) 2/39 (5%) 0.90
 Multiple 5/43 (12%) 4/39 (10%) 0.86
Physician-diagnosed atopic dermatitis 11/44 (25%) 4/38 (11%) 0.09
Self-reported allergic rhinitis 11/44 (25%) 11/39 (28%) 0.74
Physician-diagnosed asthma 6/42 (14%) 6/39 (15%) 0.89
Self-smoking 2/43 (5%) 14/40 (35%) 0.0005
Maternal smoking 15/44 (34%) 13/41 (32%) 0.82
Paternal smoking 16/41 (39%) 19/36 (53%) 0.23
Season of the surgery 0.85
 Winter (months 12–2) 7 (15%) 4 (10%)
 Spring (months 3–5) 14 (30%) 13 (31%)
 Summer (months 6–8) 8 (17%) 5 (12%)
 Fall (months 9–11) 18 (38%) 20 (48%)
Respiratory symptoms
 The operation day 6/39 (15%) 7/38 (18%) 0.72
 Within 2 weeks 16/42 (38%) 12/37 (32%) 0.60
 Within 4 weeks 23/42 (55%) 18/37 (48%) 0.59
One month prior the operation
 Throat pain 8/39 (21%) 14/35 (40%) 0.0005
 Rhinitis 23/39 (59%) 6/35 (17%) 0.0002
 Cough 15/39 (38%) 5/36 (14%) 0.02
 Acute otitis media 2/39 (5%) 0/35 (0%) 0.17
 Wheezing 2/39 (5%) 0/35 (0%) 0.17
25(OH)D level
 Total (nmol/l) 56.2 (41.7, 66.9) 45.7 (34.4, 72.3) 0.08
 Free (pg/ml) 6.4 (4.9, 8.1) 5.0 (3.3, 8.8) 0.14
 Bioavailable (ng/ml) 2.2 (1.7, 2.9) 1.6 (1.1, 2.7) 0.01
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virus in their nasopharyngeal aspirates (49 vs. 24%) or 
two viruses in their tonsils (11 vs. 0%, respectively) (both 
P < 0.05) (Table 2).
Cytokine and transcription factor expression profiles 
in tonsils
In unadjusted analysis, patients in the hypertrophy group 
had stronger tonsillar expression of Tbet (P = 0.03) and 
IL-37 (P = 0.001) than patients in the recurrent tonsillitis 
group (Tables 3, 4). In the multivariable regression analy-
sis, only age remained as a significant co-factor (Table 4). 
After adjustment for age, the expressions of only IL-37 
was independently associated with tonsillar hypertrophy 
group (P < 0.05, Fig. 2). No other differences in cytokine 
or transcription factor expression were found between 
the groups.
Discussion
This study shows differences in virus detections and T 
cell and interferon gene expressions in patients under-
going tonsillectomy due to tonsillar hypertrophy or 
recurrent tonsillitis. Patients with tonsillar hypertrophy 
were typically younger, and had more viral findings, but 
only bocavirus-1 was more often found in tonsils when 
compared to patients with recurrent tonsillitis. Respec-
tively, they also had less self-reported pollen allergy, but 
no differences were found in food allergies between the 
Table 2 Nasopharyngeal and intratonsillar virus detection
Values are shown as number of subjects (%). Data were analysed by Chi square test, or Fisher’s Exact test
Significant values are shown in italic
Virus Nasopharynx P value Tonsil P value
Tonsillar hypertrophy
n = 47
Recurrent tonsillitis
n = 42
Tonsillar hypertrophy
n = 47
Recurrent tonsillitis
n = 42
Adenovirus 9 (19%) 2 (5%) 0.03 7 (15%) 2 (5%) 0.10
Bocavirus-1 12 (26%) 2 (5%) 0.005 7 (15%) 1 (2%) 0.03
Coronavirus 3 (6%) 0 (0%) 0.048 0 (0%) 0 (0%) –
Enteroviruses 4 (9%) 4 (10%) 0.87 6 (13%) 4 (10%) 0.63
Influenza A or B virus 1 (2%) 0 (0%) 0.26 0 (0%) 0 (0%) –
Metapneumovirus 0 (0%) 1 (2%) 0.29 1 (2%) 0 (0%) 0.26
Parainfluenza virus types 1-4 1 (2%) 1 (2%) 0.94 4 (9%) 1 (2%) 0.19
Respiratory syncytial virus 1 (2%) 0 (0%) 0.26 2 (4%) 0 (0%) 0.11
Rhinovirus species A, B or C 27 (57%) 14 (33%) 0.02 2 (4%) 2 (5%) 0.91
Number of positive viruses 37 (79%) 16 (38%) < 0.0001 17 (36%) 8 (19%) 0.07
Positive for 1 virus 23 (49%) 10 (24%) 0.01 9 (19%) 7 (17%) 0.76
Positive for 2 viruses 8 (17%) 4 (10%) 0.30 5 (11%) 0 (0%) 0.01
Positive for 3 viruses 5 (11%) 2 (5%) 0.30 2 (4%) 1 (2%) 0.62
Positive for 4 viruses 1 (2%) 0 (0%) 0.26 1 (2%) 0 (0%) 0.26
Positive for ≥ 1 viruses 37 (79%) 16 (38%) 17 (36%) 8 (19%)
Positive for ≥ 2 viruses 14 (30%) 6 (14%) 8 (17%) 1 (2%)
Positive for ≥ 3 viruses 6 (13%) 2 (5%) 3 (7%) 1 (2%)
Positive for ≥ 4 viruses 1 (2%) 0 1 (2%) 0
Table 3 Intratonsillar cytokine and  transcription factor 
expression in hypertrophic tonsils and recurrent tonsillitis
Values are arbitrary units × 104 relative to EF1α
IQR, interquartile range; IFN, interferon; Tbet, T-box transcription factor; IL, 
interleukin; GATA3, GATA-binding factor 3; RORC, RAR-related orphan receptor C; 
FOXP, forkhead box protein; TGF, tumour growth factor
Cytokine 
or transcription factor
Tonsillar hypertrophy
n = 47
Recurrent tonsillitis
n = 42
Median (IQR) Median (IQR)
T-helper1
 IFN-γ 58 (37, 90) 76 (32, 117)
 Tbet 54 (31, 83) 34 (22, 60)
T-helper2
 IL-13 1.2 (0.03, 3.7) 0.45 (0.02, 2.2)
 GATA3 27 (16, 36) 18 (12, 39)
T-helper17
 IL-17 10 (5.6, 19) 7.3 (4.1, 13)
 RORC2 15 (7.2, 31) 20 (10, 28)
T-regulatory
 IL-10 49 (24, 74) 35 (21, 64)
 IL-37 0.26 (0.15, 0.37) 0.14 (0.10, 0.24)
 FOXP3 46 (20, 87) 48 (24, 80)
 TGF-β 163 (105, 232) 171 (120, 225)
Type I/III interferons
 IFN-α 15 (0.59, 62) 9.7 (0.27, 56)
 IFN-β 24 (2.7, 101) 22 (2.1, 103)
 IL-28 31 (3.1, 88) 12 (1.4, 75)
 IL-29 11 (2.3, 34) 3.7 (1.3, 26)
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groups. After age-adjusted analysis, tonsillar hypertrophy 
was associated with higher tonsillar mRNA expressions 
of IL-37. Other than age, no other significant co-factors 
were found.
IL-37 (formerly IL-1 family member 7) is a fundamen-
tal inhibitor of innate immunity [9, 10]. It has been shown 
to be expressed in macrophages, monocytes, plasma and 
epithelial cells [11]. After ligand activation, IL-37 inhibits 
inflammatory cytokines (especially IL-1β, but also IL-6, 
IL-7, IFN-γ, and TNF-α) and augments the level of anti-
inflammatory IL-10 and T regulatory cells [11]. We have 
previously shown that the expression of IL-37 is closely 
and positively associated with other “immune activa-
tion/regulatory” cytokines (IL-10, IL-17, IL-37, TGF-β, 
FOXP3, GATA3, RORC2, Tbet) in tonsils [2]. The current 
analysis adds that tonsillar expression of anti-inflamma-
tory cytokine IL-37 is also independently and positively 
associated with tonsillar hypertrophy.
Interferons (IFN-α, IFN-β, IFN-γ, IL-28, IL-29) are 
cytokines with antiviral activity and their expression is 
induced by viral infection. IL-28 and IL-29 are members 
of IFN-λ family [12, 13]. They are produced by dendritic 
Table 4 Differences in cytokine and transcription factor expression between hypertrophic tonsils and recurrent tonsillitis
Data are expressed as mean differences as a recurrently infected group minus hypertrophic group. The data were analysed using backward stepwise linear regression 
analysis after logarithmic transformation. Only significant co-factors were used as adjustments in the final model
CI, confidence interval; IFN, interferon; Tbet, T-box transcription factor; IL, interleukin; GATA3, GATA-binding factor 3; RORC, RAR-related orphan receptor C; FOXP, 
forkhead box protein; TGF, tumour growth factor
Significant values are shown in italic
Cytokine or transcription factor Mean differences recurrently infected minus hypertrophic group
Univariate Multivariate
n Difference of means (95% CI) Adjusted difference of means (95% CI) Adjustments
T-helper1
 IFN-γ 88 0.061 (− 0.32, 0.44)
P = 0.75
– –
 Tbet 89 − 0.40 (− 0.76, − 0.034)
P = 0.03
− 0.21 (− 0.61, 0.18)
P = 0.29
Age
T-helper2
 IL-13 89 − 0.74 (− 1.8, 0.36)
P = 0.18
– –
 GATA3 89 − 0.12 (− 0.42, 0.18)
P = 0.43
– –
T-helper17
 IL-17 89 − 0.35 (− 0.80, 0.096)
P = 0.12
− 0.087 (− 0.57, 0.40)
P = 0.72
Age
 RORC2 89 0.014 (− 0.35, 0.38)
P = 0.94
– –
T-regulatory
 IL-10 89 − 0.26 (− 0.61, 0.0871)
P = 0.14
− 0.0070 (− 0.38, 0.36)
P = 0.97
Age
 IL-37 87 − 0.48 (− 0.77, − 0.19)
P = 0.001
− 0.31 (− 0.63, − 0.0021)
P = 0.049
Age
 FOXP3 89 0.091 (− 0.31, 0.49)
P = 0.65
– –
 TGF-β 89 − 0.0077 (− 0.32, 0.30)
P = 0.96
– –
Type I/III interferons
 IFN-α 87 − 0.41 (− 1.5, 0.7)
P = 0.47
– –
 IFN-β 88 − 0.21 (− 1.0, 0.61)
P = 0.62
– –
 IL-28 89 − 0.64 (− 1.5, 0.2)
P = 0.13
– –
 IL-29 87 − 0.57 (− 1.5, 0.31)
P = 0.15
– –
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cells and macrophages following viral infection or acti-
vation with bacterial components [12–14]. We expected 
to see differences in IFN expression (lower responses in 
recurrent tonsillitis than in tonsillar hypertophy group), 
since they have antiviral properties and they up-regu-
late the expression of MHC Class II molecules on cells 
which increases the immune system’s ability to recognize 
viruses [14, 15]. However, we did not observe these dif-
ferences. We speculate that tonsillar hypertophy may be 
a consequence of chronic inflammation in tonsils and the 
same interferon pathways are equally activated in both 
conditions. We have previously found strong intragroup 
correlations of tonsillar IFN expression(IFN-α, IFN-β, 
IFN-γ, IL-28) [2].
Age was the main clinical characteristic differentiating 
the tonsillectomy indication groups. In agreement with 
previous findings [16], we found that obstruction due to 
the hypertrophy is more common with younger children 
where as adults have more recurrent tonsillitis. The age 
difference between the groups also explains the differ-
ences in smoking and in additional adenotomy performed. 
Interestingly, Reis and colleagues found no difference 
between the age distribution of hypertrophy and tonsillitis 
patients, but the narrow age range of their subjects (ages 
2–11 years) may explain the lack of difference [17].
Virus was found in the nasopharynx of 79% of patients 
with tonsillar hypertrophy group and 38% in recur-
rent tonsillitis group. Most often detected viruses were 
adenovirus, bocavirus-1, coronavirus and rhinovirus. 
However, intratonsillar virus detection was low and did 
not show any statistically significant differences except 
for bocavirus-1. The results of nasopharyngeal and intra-
tonsillar virus detection vs tonsillar cytokine responses 
are discussed in detail in our previous report [2].
Small differences in cytokine expression may partly 
be explained by differences concerning tonsillar germi-
nal centers. The mean follicular area has been found to 
be larger, and the number of germinal centers higher, in 
the hypertrophy group compared to the recurrent tonsil-
litis [17–19]. In our study, the samples were taken from 
inside of the tonsils to minimize the margin of error and 
the possibility to misinterpreted differences between the 
groups. Seasonal changes, e.g. pollen and influenza sea-
sons, may affect the expression of peripheral T cells [20], 
but we found no differences in tonsillar expression of 
cytokines between the seasons of the surgery. Also, res-
piratory viruses are continuously detected in children 
with chronic tonsillitis throughout the year [21–23]. Cir-
culating serum 25(OH)D level has been shown to been 
positively associated with IL-37 level [3], but here it did 
not confound the results.
A limitation of the current study is that we did not 
investigate bacterial colonization of the tonsils in these 
patients due to fact that the operation was done during 
an afebrile period of their chronic tonsil condition. The 
downstream signaling of IL-37 is a complex process and 
to show functionality of IL-37 by downstream mediators 
was not in the scope of this study. In addition to forming 
cell-surface receptor complexes, IL-37 translocates to the 
nucleus where it binds to nuclear DNA and participate in 
transcription. [24, 25] IL-37 is regarded as a “dual func-
tion” cytokine, similar to IL-1α and IL-33.
Conclusions
In summary, this study provides new insights about T 
cell research in lymphoid tissue from the clinical aspect 
of the surgical indication for tonsillectomy. We found 
tonsils as a good in  vivo model for investigating the 
mechanisms of inflammatory processes and infections in 
lymphoid organs. Our data suggest that T-cell and inter-
feron gene expressions appear to relatively stable over the 
two main indications of tonsillectomy, tonsillar hypertro-
phy and recurrent tonsillitis. However, anti-inflamma-
tory immune responses, namely IL-37, might be slightly 
stronger in patients with tonsillar hypertrophy than with 
patients with recurrent tonsillitis.
Additional file
Additional file 1. Health questionnaire.
Fig. 2 Relative tonsillar expression of IL-37. Forty-two recurrent 
tonsillitis samples compared with 47 hypertrophic tonsil samples. 
Values are arbitrary units x  104 relative to EF1α. Data are represented 
as median with interquartile range. IL-37, Interleukin 37
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